Precigen (STU:I5X) Short Interest


STU:I5X Precigen Inc STU:I5X
62 GF Score
Price €4.92
GF Value €5.31
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Precigen Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:I5X vs KARD, SLBT, GENB: Short Interest Comparison

For the Biotechnology subindustry, Precigen's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Precigen Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precigen's Short Interest distribution charts can be found below:

* The bar in red indicates where Precigen's Short Interest falls into.


STU:I5X
62GF Score
Precigen Inc STU:I5X
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Precigen (STU:I5X) Overvalued in 2026?

Based on GuruFocus' analysis, Precigen stock appears to be undervalued. The current stock price of €4.92 is trading 7.3% below its estimated GF Value™ of €5.31. GuruFocus considers Precigen to be Fairly Valued.

Key valuation signals for STU:I5X:

  • Short Interest:
  • GF Value™: €5.31 vs. price of €4.92 (7.3% below fair value)
  • GF Score™: 62/100 with 10 warning signs

No single metric tells the full story. See the STU:I5X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precigen Business Description

Other Exchanges PGEN:USA
Address 20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
62GF Score

Get the complete analysis for STU:I5X

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.92
Price
€5.31
GF Value